Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
filingDate |
2010-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2013508371-A |
titleOfInvention |
Method for treating Alzheimer's disease by increasing the activity of gangliosides using pharmacological chaperones |
abstract |
The present invention relates to a method for treating individuals with Alzheimer's disease by using pharmacological chaperones to increase the activity of gangliosidase and / or sialidase enzymes involved in ganglioside catabolism. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019132004-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018528953-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013508366-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017511372-A |
priorityDate |
2009-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |